stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs ANI Pharmaceuticals, Inc. (ANIP)
- Amphastar Pharmaceuticals, Inc. AMPH 28.35 +2.49%
- ANI Pharmaceuticals, Inc. ANIP 68.77 −1.22%
Amphastar Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.6B against $1.2B — 1.4× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 13.3×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 25.9% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs 11.2%) and the lower return on invested capital (6.12% vs 46.4%). Across the 22 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Amphastar Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | AMPH | ANIP | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 61.06% | 53.51% |
| Operating margin | 18.74% | 15.99% | 0.00% |
| Net margin | 13.27% | 11.22% | (2.45%) |
| Free cash flow margin | 18.64% | 19.72% | 0.00% |
| Return on equity | 12.44% | 20.45% | (0.80%) |
| Return on assets | 5.86% | 7.85% | (1.67%) |
| Return on invested capital | 6.12% | 46.43% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack